Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Debt Ratio (2016 - 2025)

Integra Lifesciences Holdings' Debt Ratio history spans 17 years, with the latest figure at 0.48 for Q4 2025.

  • For Q4 2025, Debt Ratio rose 16.71% year-over-year to 0.48; the TTM value through Dec 2025 reached 0.48, up 16.71%, while the annual FY2025 figure was 0.48, 16.71% up from the prior year.
  • Debt Ratio for Q4 2025 was 0.48 at Integra Lifesciences Holdings, roughly flat from 0.48 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.48 in Q4 2025 and bottomed at 0.2 in Q4 2022.
  • The 5-year median for Debt Ratio is 0.24 (2022), against an average of 0.3.
  • The largest annual shift saw Debt Ratio decreased 22.13% in 2021 before it skyrocketed 85.22% in 2024.
  • A 5-year view of Debt Ratio shows it stood at 0.23 in 2021, then decreased by 13.72% to 0.2 in 2022, then grew by 12.03% to 0.22 in 2023, then skyrocketed by 85.22% to 0.41 in 2024, then grew by 16.71% to 0.48 in 2025.
  • Per Business Quant, the three most recent readings for IART's Debt Ratio are 0.48 (Q4 2025), 0.48 (Q3 2025), and 0.46 (Q2 2025).